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A B S T R A C T
Introduction. Across all specialties, economic pressure is driving increased utilization of outpatient surgery when
feasible.
Aims. Our aims were to analyze national trends of penile prosthesis (PP) surgery and to examine patient and hospital
characteristics, and perioperative complications in the inpatient setting.
Methods. We analyzed data from National Inpatient Sample. Patients in NIS who underwent PP insertion between
2000 and 2010 were included.
Main Outcome Measures. Our main outcomes were the number of inpatient PP procedures, type of prosthesis,
patient demographics, comorbidities, hospital characteristics, and immediate perioperative complications.
Results. There was a progressive and dramatic decline by nearly half in the number of both inﬂatable (IPP) and
noninﬂatable (NIPP) inpatient insertions performed from 2000 to 2010 (P = 0.0001). The overall rate of inpatient
complications for PP insertion was 13.5%. Patients with three or more comorbidities were found to have a higher
risk of complications than patients with no comorbidities (OR = 1.45, 95% CI = 1.18–1.78) (P = 0.0001). Surgeries
performed in high-volume hospitals (10 or more PP cases per year) were associated with reduced risk of complica-
tions (OR = 0.6) (P < 0.0001). There was a dramatic decrease in inpatient setting for PP placement in high-volume
hospitals (32% in 2000 compared with 6% in 2010; P < 0.0001), and when compared with lower volume hospitals.
NIPP was more likely performed in younger patients and in community hospitals, and less likely in white patients.
Medicaid health insurance was associated with much higher rate of NIPP insertion than other types of insurance.
Conclusions. The number of PP procedures performed in the inpatient setting declined between 2000 and 2010,
likely reﬂecting a shift toward increasing outpatient procedures. Our data also suggest a better outcome for patients
having the procedure done at a high-volume center in terms of inpatient complications. Alwaal A, Harris CR,
Hussein AA, Sanford TH, McCulloch CE, Shindel AW, and Breyer BN. The decline of inpatient penile
prosthesis over the 10-year period, 2000–2010. Sex Med 2015;3:280–286.
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Introduction
Erectile dysfunction (ED) affects more thanhalf of men between 40 and 70 years of age
[1]. Penile prosthesis (PP) placement is the gold
standard treatment for ED among men who are
unwilling to use, not candidates for, or refractory
to medical management [2]. There are two types
of PP; noninﬂatable (NIPP) and inﬂatable (IPP)
types; the latter is associated with generally higher
patient and partner satisfaction rates [3]. Utiliza-
tion of PP appears to be increasing, with approxi-
mately 17,540 PP placed in 2000 compared with
22,420 in 2009 [4]. In addition, Medicare records
from 2002 to 2012 show a slightly increased per-
formance of IPP from 4615 in 2002 to 5328 in
2010 (see Figure S1) [5].
Over 70% of surgical procedures in the United
States are performed in the outpatient setting
[6,7]. Outpatient surgery is generally more cost-
effective with an acceptable safety proﬁle for most
procedures [6,8]. While most outpatient surgeries
are performed in hospital outpatient departments,
utilization of nonhospital ambulatory surgery
centers and physician ofﬁces for surgical proce-
dures has increased by 300% over the last decade
[7,8].
Several large single-center series have demon-
strated the safety and economic advantage of PP
insertion in the outpatient setting [9–11], with one
series showing a 17% reduction in ﬁnancial cost
[12]. We were interested in understanding the
national trends in the number and type of inpa-
tient PP and perioperative outcomes of PP per-
formed in the inpatient setting over time. We
hypothesized that the number of inpatient PP
insertions has declined over time.
Materials and Methods
Data Source
For our analysis of inpatient PP, we utilized the
National Inpatient Sample (NIS), the largest pub-
licly available, all-payer inpatient care database in
the United States [13]. NIS contains data from
approximately 1000 hospitals in 37 states and
includes 8 million inpatient hospital admissions
per year; this sample represents approximately
20% of all hospital admissions in the United States
[13].
Inclusion Criteria
All patients in NIS who underwent PP insertion
between January 1, 2000 and December 31, 2010
were candidates for inclusion. Subjects were iden-
tiﬁed using the International Classiﬁcation of Dis-
eases (ICD-9-CM)procedure codes for insertion of
IPP (64.97) andNIPP (64.95). Two urologists (A.A.
and B.N.B.) evaluated this data to ensure that the
patients included in the analysis did undergo PP
insertion and not a different surgery. Some patients
were excluded because of major concurrent proce-
dures that would preclude concomitant PP
insertion in the same admission, such as radical
cystectomy, as it would most likely be a result of an
error in coding.We elected to include patients who
hadPPplacement in combinationwith otherminor
procedures, including removal of PP prior to
replacement (64.96), artiﬁcial urinary sphincter
insertion (5893), inguinal hernia repair (5300,
5301, 5302, 5303, 5304, 5305, 5314, 5317, 5321),
abdominal hernia repair (5341, 5349, 5351,
5359, 5361, 5369), hydrocelectomy (612, 617), cir-
cumcision (640), orchiectomy (623, 6241),
varicocelectomy (631), vasectomy (6373), and
epididymal cyst excision (632). We have also iden-
tiﬁed PP revision cases through the presence of the
PP removal ICD-9 procedure code (64.96) in the
same inpatient admission along with one of the two
codes of insertion (64.97 or 64.95).
Predictors
We abstracted demographic data fromNIS includ-
ing patient age (grouped as patients aged 18–44,
45–64, and ≥65 years), race (white, black, and
other), number of medical co-morbidities such as
hypertension (0, 1, 2, and ≥ 3) as deﬁned and pre-
viously validated by NIS [13], year of operation,
hospital size (small, medium, and large), number
of PP inserted per year at each hospital (grouped
as 1, 2–9, and 10 or more), payer type (Medicare,
Medicaid, private insurance, and other), and geo-
graphic region (Northeast, Midwest, South, and
West) [13].
Outcome Variables
Our primary outcomes were trends of PP insertion
across the different categories according to the
type of prosthesis and inpatient complications. In
addition, we analyzed trends in the number of
inpatient PP insertion performed over the last
decade, and examined the change in trends of
inpatient PP insertion in terms of patient
comorbidity and hospital volume of PP cases/year.
We analyzed the prevalence and type of com-
plications whether surgical or medical. Complica-
tions were divided into surgical complications
(e.g., wound and genitourinary complications) and
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medical complications (e.g., cardiovascular, respi-
ratory, gastrointestinal, neurologic, and musculo-
skeletal complications) (see Table S1).
Statistics
Data analysis was performed using sas (version
9.2, SAS Institute Inc, Cary, NC, USA). All analy-
ses accounted for the complex survey design and
the sampling weights of the NIS. Bivariate logistic
regression was used to measure the association
between patient and hospital characteristics and
the presence of an inpatient complication (yes/no).
We also examined the association of patient and
hospital factors and type of PP insertion using a
chi-squared test. P values less than 0.05 were con-
sidered statistically signiﬁcant.
Results
National Trends of PP Insertion
Analysis of NIS data revealed a progressive decline
of the number of inpatient PP insertions (for both
IPP and NIPP) performed from 2000 to 2010, by
nearly half (P = 0.0001) (Figure 1). Patients with
three or more comorbidities comprised a progres-
sively higher percentage of overall inpatient PPs
performed (6% in 2000 to 19% in 2010)
(P < 0.0001) (Figure 2), while high-volume hospi-
tals performing 10 or more inpatient PP insertion
cases per year performed progressively less over
time from 32% in 2000 to 6% in 2010 (P < 0.0001)
(Figure 3).
Inpatient Complications
The overall rate of inpatient complications for
PP insertion was 13.5%. Surgical complications
were the overwhelming majority representing
82% of them, while medical complications rep-
resented 14% and the remaining 4% were
patients who experienced combined medical and
surgical complications.
Patients with three or more comorbidities were
found to have a higher risk of complications than
patients with no comorbidities (OR = 1.45, 95%
CI = 1.18–1.78) (P = 0.0001). High-volume hospi-
tals (deﬁned as performing 10 or more PP inser-
tion cases per year) were associated with reduced
risk of complications (OR = 0.6, 95% CI = 0.5–
0.76) (P < 0.0001). Patient age, race, or hospital
size were not associated with risk of complications
(Table 1). Replacement of PP comprised 1.13% of
inpatient PP insertion cases, with an increased risk
of complications (OR 4.93, 95% CI 3.31–7.35).
National Trends of Inpatient PP Types
When we analyzed the procedures according to
the type of prosthesis inserted, we found NIPP to
be more commonly performed in younger patients
Figure 1 Volume of inpatient PP in the United States from 2000 to 2010. IPP, inflatable penile prosthesis; NIPP,
noninflatable penile prosthesis; whiskers, 95% confidence interval
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(13.4% vs. 9–10%) (P = 0.012) and less likely to be
performed in white patients (8.3% vs. 12.3–
14.6%) (P < 0.0001). NIPP was also found to be
more likely to be performed in community hospi-
tals than academic (12.7% vs. 7.1%) (P < 0.0001),
and more likely to be performed in the northeast
and the west (15.9% and 12.8%, respectively)
(P < 0.0001). Medicaid health insurance was asso-
ciated with much higher rate of NIPP insertion
(20.9%) than other types of insurance (9–10%)
(P < 0.0001). There was no difference in the rate
of NIPP insertion when compared by hospital size,
patient comorbidity, or PP insertion cases per year
(Table 2).
Figure 2 Patient comorbidities of inpatient PP from 2000 to 2010. 0, no comorbidity; 1, one comorbidity; 2, two
comorbidities; 3+, three or more comorbidities
Figure 3 Hospital volume of inpatient penile prosthesis from 2000 to 2010. 1, one case/year; 2–9, two to nine cases/year;
10+, 10 or more cases/year
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Discussion
While there are several treatments available for
ED, PP remains a valuable and effective option
when others have failed or are contraindicated [2].
Little data are available to estimate the overall
number of PPs inserted [14]. Market research data
andMedicare records for performance of IPP have
Table 1 Patient and hospital characteristics and complication rates for penile prosthesis insertion
Characteristic
Patients,
n (%)
Complications,
n (%) OR (95% CI) P value
Age 18–44 2,523 (5.2) 383 (15.17) 1.00 0.53
45–64 22,128 (45.57) 2,952 (13.34) 0.86 (0.66–1.12)
65+ 23,905 (49.23) 3,211 (13.43) 0.87 (0.67–1.13)
Race White 25,346 (66.56) 3,431 (13.54) 1.00 0.27
Black 6,881 (18.07) 899 (13.07) 0.96 (0.79–1.16)
Other 5,851 (15.37) 680 (11.63) 0.84 (0.68–1.04)
Comorbidity 0 16,540 (34.07) 2,179 (13.18) 1.00 0.0001
1 16,310 (33.59) 1,974 (12.11) 0.91 (0.79–1.05)
2 10,778 (22.2) 1,504 (13.95) 1.07 (0.91–1.26)
3 or more 4,927 (10.15) 888 (18.02) 1.45 (1.18–1.78)
Payer Medicare 27,142 (56) 3,727 (13.73) 1.00 0.33
Medicaid 1,069 (2.2) 180 (16.8) 1.27 (0.87–1.86)
Commercial 18,683 (38.5) 2,443 (13) 0.95 (0.83–1.07)
Other 1,661 (3.4) 196 (11.8) 0.84 (0.61–1.16)
Hospital size Small 4,234 (8.75) 557 (13.16) 1.00 0.06
Medium 12,618 (26.06) 1,495 (11.85) 0.89 (0.66–1.19)
Large 31,564 (65.19) 4,479 (14.19) 1.09 (0.84–1.43)
Region Northeast 10,103 (20.8) 1,222 (12.1) 1.00 0.09
Midwest 8,403 (17.3) 1,163 (13.88) 1.17 (0.91–1.5)
South 19,803 (40.8) 2,893 (14.6) 1.24 (1–1.5)
West 10,246 (21.1) 1,268 (12.4) 1.03 (0.83–1.28)
Hospital type Community 23,587 (48.7) 3,120 (13.2) 1.00 0.56
Academic 24,830 (51.3) 3,412 (13.7) 1.04 (0.9–1.21)
Volume (PP cases/year) 1 6,982 (14.38) 1,170 (16.75) 1.00 <0.0001
2–9 28,494 (58.68) 3,976 (13.96) 0.82 (0.69–0.97)
10+ 13,079 (26.94) 1,400 (10.70) 0.61 (0.5–0.76)
CI, confidence interval; N = number; OR = odds ratio; PP = penile prosthesis. Bold results = statistically significant, p < 0.05.
Table 2 Comparison between patient and hospital characteristics and type of penile prosthesis perform
Characteristic Category IPP n (%) NIPP n (%) P value
Age 18–45 2,179 (86.6) 338 (13.4) 0.0123
45–65 19,849 (89.75) 2,268 (10.25)
65+ 21,659 (90.65) 2,235 (9.35)
Race White 23,237 (91.7) 2,099 (8.3) <0.0001
Black 5,871 (85.4) 1,004 (14.6)
Other 5,127 (87.7) 720 (12.3)
Number of comorbidities 0 14,833 (89.7) 1,696 (10.3) 0.242
1 14,816 (90.9) 1,489 (9.1)
2 9,674 (89.8) 1,099 (10.2)
3 or more 4,365 (88.7) 557 (11.3)
Payer Medicare 24,488 (90.3) 2,638 (9.7) <0.0001
Medicaid 845 (79.1) 224 (20.9)
Commercial 16,872 (90.4) 1,801 (9.6)
Other 1,483 (89.3) 178 (10.7)
Hospital size Small 3,938 (93) 296 (7) 0.105
Medium 11,424 (90.54) 1,194 (9.46)
Large 28,202 (89.4) 3,336 (10.6)
Region Northeast 8,500 (84.1) 1,603 (15.9) <0.0001
Midwest 7,704 (91.8) 688 (8.2)
South 18,559 (93.7) 1,244 (6.3)
West 8,924 (87.2) 1,307 (12.8)
Hospital type Academic 21,668 (92.9) 3,151 (7.1) <0.0001
Community 21,897 (87.3) 1,675 (12.7)
Volume (PP cases/year) 1 6,125 (87.8) 852 (12.2) 0.262
2–9 25,842 (90.7) 2,636 (9.3)
10 + 11,720 (89.7) 1,354 (10.3)
IPP = inflatable penile prosthesis; n = number; NIPP = non-inflatable penile prosthesis. Bold results = statistically significant, p < 0.05.
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shown an overall increased utilization of PP over
the last decade, despite the introduction of type 5
phosphodiesterase inhibitors [4,5]. Our data indi-
cate that during that same period of time, inpatient
hospitalizations for PP have declined, likely sug-
gesting that more PP procedures are being per-
formed in outpatient settings. There is a growing
trend toward increasing the utilization of outpa-
tient surgery, which has been shown for many
procedures to be safe and effective at reducing
healthcare costs by shortening hospital stay [15].
We analyzed the trends of patient and hospital
characteristics associated with inpatient PP inser-
tion over the last decade. With time, there was an
increase in the percentage of patients with three
or more comorbidities (Figure 2). Also, there was
a signiﬁcant drop in the percentage of inpatient
PP by hospitals performing 10 or more PPs per
year, from 32% in 2000 to only 6% in 2010. This
is likely representing that sicker patients are more
likely to need inpatient care rather than the out-
patient option and that high-volume centers are
conﬁdent enough with the procedure to perform
it in outpatient settings (Figure 3).
The overall perioperative inpatient complica-
tion rate was 13.5%. This complication rate is
slightly higher than the previously reported rates
of 7–10% for PP surgery [16,17]. Race and age
were not associated with the complication rate.
However, high-volume (PP cases/year) hospitals
had a lower complication rates than other hospitals
(P < 0.0001). Since high-volume hospitals are per-
forming less inpatient PP insertions with time, it is
possible that our reported higher complication
rate is due to performance of this procedure by
predominantly less experienced surgeons, who are
performing it in an inpatient setting.
To our knowledge, there have been no previous
studies looking at a national-level data analysis of
patient and hospital characteristics related to
NIPP. NIPP was surprisingly performed slightly
more in younger patients. It was also more likely
to be performed in the West and the Northeast.
White patients tend to be more likely to have IPP
than NIPP (see Table 2), possibly reﬂecting a
better socio-economic status for those patients.
Community hospitals tend to perform more NIPP
than academic hospitals, possibly due to patient
characteristics and/or insurance issue. By far, inpa-
tient NIPP was more likely to be performed in
Medicaid patients (20.9%) than other types of
health insurance, which could be explained by the
fact that Medicaid usually covers NIPP, not IPP.
Hospital size, comorbidity, or volume of inpatient
PP cases/year were not associated with the type of
inpatient PP performed.
There are limitations in our study. First, NIS
only contains inpatient data, and do not include
23-hour stay. While our aim was to analyze inpa-
tient PP use, having comparative outpatient data
would have strengthened our ﬁndings. Second, the
reported complication rates are for the inpatient
admission only and do not reﬂect long-term com-
plications or readmissions. Third, we were limited
by the ICD-9 coding system, which is not a
detailed system to catalogue complications.
Therefore, we could not comment on complica-
tion details such as device malfunction or erosion.
Furthermore, administrative data fromNIS do not
provide granular data regarding health status and
disease states. In addition, we were unable to assess
the severity of complications using a standardized
system such Clavien-Dindo.
Conclusions
The number of inpatient PP procedures is declin-
ing over the years, likely reﬂecting a shift toward
increasing outpatient procedures. Our data suggest
a better outcome for patients having the procedure
done at a high-volume center in terms of inpatient
complications, and a possible shift in these high-
volume centers to performing the procedure as an
outpatient. Therefore, consideration can be made
for referring these cases to high-volume centers in
order to have a better outcome and reduce ﬁnancial
expenditure. Further research and analysis are
much needed, particularly a nationwide outpatient
data analysis, in order to analyze the overall trends
and complications of PP insertion.
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